Your browser doesn't support javascript.
loading
Detection and clinical application of minimal residual disease in multiple myeloma / 国际肿瘤学杂志
Article en Zh | WPRIM | ID: wpr-693443
Biblioteca responsable: WPRO
ABSTRACT
Minimal residual disease (MRD) is a very important prognostic factor in multiple myeloma (MM).The major types of MRD tests include cell-based test (multi-parameter flow cytometry) and molecular tests (including PCR and gene sequencing),and the various techniques have inherent advantages and limitations.In clinical application,MRD negative can significantly prolong progression-free survival and overall survival of patients who receive hematopoietic stem cell transplantation and conventional che-motherapy.Moreover,the MRD status is of great significance to the selection of treatment options.
Palabras clave
Texto completo: 1 Base de datos: WPRIM Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: Zh Revista: Journal of International Oncology Año: 2018 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: Zh Revista: Journal of International Oncology Año: 2018 Tipo del documento: Article